Scalper1 News
Is it time for WebMD Health (WBMD) stock to break out? At least one analyst thinks so. Sandy Draper at SunTrust Robinson Humphrey has upgraded shares of the online medical information site to buy from neutral and raised his price target to 52 from 50. Draper sees the biopharmaceutical industry’s ad market — critical to WebMD’s success — growing by double digits and private portal growth boosting revenue over the next two years. He points out that Scalper1 News
Scalper1 News